Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsCreative Biolabs, with over two decades of pioneering experience in antibody engineering, offers a world-class BOUND Antibody Recognized Anti-Idiotypic Antibody Discovery Service. We are dedicated to providing the biopharmaceutical industry with exquisitely specific and high-affinity anti-idiotypic antibodies (anti-ID Abs) that recognize the antibody drug-target complex. These critical reagents are the cornerstone of robust and reliable PK assays, enabling you to gain a complete and accurate picture of your drug's behavior in vivo. Our services are tailored for research and preclinical development, empowering you to make data-driven decisions with confidence.
To fully characterize a therapeutic antibody's PK profile, it is essential to distinguish between three forms of the drug in a biological matrix:
An anti-idiotypic antibody is a specialized antibody that binds to the unique idiotope (variable region) of another antibody. For PK studies, different types of anti-ID Abs are required to measure the different drug forms. A BOUND Anti-ID Antibody, also known as a complex-specific anti-ID, is uniquely designed to recognize an epitope that is only formed when the therapeutic antibody is bound to its target antigen. It will not bind to the free drug or the free target, ensuring unparalleled specificity in your assays.
Fig. 1 Types of anti-idiotypic antibody.
The ability to specifically quantify the bound drug fraction is critical for:
At Creative Biolabs, we understand that a one-size-fits-all approach is insufficient for the complexities of modern biologics. We have therefore established a suite of state-of-the-art technology platforms to generate high-quality, complex-specific anti-idiotypic antibodies tailored to your specific therapeutic antibody and project needs.
Our primary strategy for discovering bound-specific anti-ID Abs involves a meticulous competitive selection process. We immobilize the antibody-antigen complex to serve as the selection target, while using a surplus of free therapeutic antibody, free target antigen, and isotype control antibodies in the solution phase as competitors. This elegant approach ensures that only the phages or B cells displaying antibodies that exclusively recognize the unique neo-epitope of the drug-target complex are isolated and advanced.
Table 1. Comparison of Our Anti-ID Antibody Discovery Platforms
| Platform Technology | Key Advantages | Best Suited For |
| Phage Display Technology | High throughput, precise control over selection pressures, ability to generate fully human antibodies, circumvents immunotolerance. Ideal for generating antibodies against complex epitopes. | Projects requiring high specificity, human antibody formats, and rapid development timelines. |
| Hybridoma Technology | Generates monoclonal antibodies with high affinity and specificity through in vivo affinity maturation. Robust and well-established platform. | Generating high-affinity rodent monoclonal antibodies for traditional assay development. |
| Single B Cell Screening | Isolates rare B cells with desired specificity directly from immunized animals. Captures natural antibody repertoires with native heavy and light chain pairing. | Projects demanding the highest possible affinity and epitope diversity. |
| Chicken IgY Antibody Platform | Utilizes the phylogenetic distance of avian species to generate a robust immune response against conserved mammalian protein targets, overcoming tolerance issues. | Highly conserved targets where traditional mammalian systems fail. |
We believe in transparency and collaboration. Our project workflow is designed to be efficient, predictable, and keep you informed at every stage.
The primary application of our complex-specific anti-idiotypic antibodies is the development of highly specific and sensitive pharmacokinetic (PK) assays. These reagents are instrumental in:
Creative Biolabs offers a comprehensive suite of services to support your entire antibody drug development program. Explore our related offerings:
Ready to gain deeper insights into your therapeutic antibody's pharmacokinetic profile? Contact us today to discuss your project with one of our PhD-level experts. Let's accelerate your research together.
Q1: What materials do I need to provide to start a project?
A: Typically, we require 1-2 mg of your therapeutic antibody and a similar amount of the target antigen. We can also assist with antigen production if needed. Our project managers will provide a detailed list based on your specific project design.
Q2: How do you ensure the anti-ID antibody is specific to the complex?
A: Our core strategy is built around competitive screening. By incubating our libraries with the immobilized drug-target complex in the presence of a large excess of both the free drug and free target, we create a high-stringency environment where only true complex-specific binders can be enriched and isolated. Every candidate is then rigorously validated using SPR and other methods.
Q3: Can you develop anti-ID antibodies for any type of antibody therapeutic?
A: Yes. Our platforms are suitable for a wide range of formats, including monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), antibody-drug conjugates (ADCs), and antibody fragments like Fab or scFv.
Q4: What is the typical affinity of the antibodies you deliver?
A: We consistently deliver anti-idiotypic antibodies with high affinity, typically in the single-digit nanomolar to picomolar range (KD < 10 nM), ensuring excellent sensitivity for your PK assays.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
